RET-IN-23
RET-IN-23 is a potent and orally bioavailable small molecule inhibitor targeting RET, demonstrating significant anti-tumor efficacy in non-small cell lung cancer (NSCLC) models. It is a valuable research tool for investigating RET-driven oncogenesis in both in vitro cellular assays and in vivo xenograft studies.
Product Specifications
CAS Number
2479961-46-9
Field of Research
Cell Biology, Signal Transduction
Purity
97.46% (May vary between batches)
Smiles
FC=1C=NN (C1) C2=NC=C (C=C2) CN3C4CN (C5=NC=C (C=C5) C6=NC (=CC (=N6) C) NC7=NNC (=C7) C) CC3C4
Molecular Formula
C28H28FN11
Molecular Weight
537.59
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![2-Cyclopentyl-4- (5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl-benzoic acid](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
QKB84228 50 mg
2-Cyclopentyl-4- (5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl-benzoic acid
Sign In for Pricing
View Details 
K6948605 3x 1.0 µg
Kcnj12 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
Sign In for Pricing
View Details 
MPC0955K Each
Magic™ Membrane Protein Human TRPC1 (Transient receptor potential cation channel subfamily C member 1) Full Length
Sign In for Pricing
View Details abx376626-01 50 µg
Human Enterovirus 71 Genome Polyprotein Antibody
Sign In for Pricing
View Details